share_log
Breakings ·  Jun 11 12:01
Enliven Therapeutics Inc : Baird Initiates Coverage With Outperform Rating; Target Price $32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment